相关实验视频

Updated: Jul 11, 2025

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

探索登革热病毒的目标和潜在抑制剂的设计

Sayan Nath¹, Piyali Malakar¹, Baisakhi Biswas¹

¹Cell and Developmental Biology Special, Department of Zoology, University of Kalyani, Kalyani, Nadia, 741235, India.

Combinatorial chemistry & high throughput screening

|November 14, 2023

概括

这项研究使用分子对接对抗登革热病毒 (DENV) 蛋白质的合成和天然抑制剂进行了选. 这些发现可能有助于开发新的登革热治疗方法.

科学领域:

病毒学病毒学
药物发现药物发现药物发现
计算化学的计算化学

背景情况:

登革热病毒 (DENV) 感染对全球健康构成重大威胁,特别是在热带和亚热带地区.
特定抗病毒药物的有限可用性有助于增加死亡率.
了解DENV的致病性对于开发有效的治疗方法至关重要.

研究的目的:

通过识别潜在的药物点来探索DENV病理生物学.
选合成和天然抑制剂与已识别的DENV标.
通过计算药物设计来加强登革热治疗.

主要方法:

利用分子对接模拟来选潜在的抑制剂.
专注于登革热病毒的三种结构性和七种非结构性 (NS) 蛋白质.
评估了合成和天然化合物库的抑制活性.

主要成果:

确定了几种潜在的抑制剂,向关键的DENV蛋白.
分子对接分析提供了关于抑制剂-标相互作用的见解.
查结果表明有希望的候选人进一步药物开发.

结论:

选的抑制剂显示出设计新型抗登革热化合物的潜力.
这些发现可能会导致针对登革热及其并发症的新治疗策略.
进一步的研究可以建立在这些结果的基础上,用于药物开发.

关键词:

登革热病毒 (DENV) 是一种病毒.基于对接的选.非结构性蛋白质.潜在的目标是潜在的目标.结构性蛋白质是一种结构性蛋白质.合成和天然的抑制剂.

更多相关视频

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

Published on: November 1, 2018

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

相关概念视频

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...